Balaxi Pharmaceuticals Investor Relations Material
Latest events
Q1 25/26
5 Aug, 2025
Q4 24/25
30 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Balaxi Pharmaceuticals Limited
Access all reports
Balaxi Pharmaceuticals Limited is a pharmaceutical company engaged in the manufacturing, marketing, and distribution of branded generic formulations. The company offers a wide range of dosage forms including tablets, capsules, syrups, and injectables across various therapeutic segments such as anti-infectives, gastroenterology, and pain management. The company is headquartered in Hyderabad, India, and its shares are listed on the BSE.
Key slides for Balaxi Pharmaceuticals Limited
Q1 25/26
Balaxi Pharmaceuticals Limited
Q1 25/26
Balaxi Pharmaceuticals Limited
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
BALAXI
Country
🇮🇳 India